Low dose Cytarabine is currently the gold standard for non-intensive treatment of Acute Myeloid Leukaemia in the elderly.
It is given by sub-cutaneous injection twice daily for 10 days every 4-6 weeks for 4 courses or more, in total 80 contacts.
Location of delivery varies according to access to community and primary care services which are essential for delivery and completion of the 10 day twice daily schedule.
These patients have a shortened life expectancy so many prefer to spend time at home, not attending numerous hospital appointments with this regimen.
Despite their poor prognosis patients are well enough to be treated at home with access to support as required.
Within South Tees NHS Foundation Trust, patients and relatives requested to self/relative administer Cytarabine
The Haematology Chemotherapy team were keen to developed a protocol providing a practice framework to ensure safe delivery of chemotherapy, whilst ensuring a quality service that enabled patients to have effective treatment and choice of treatment delivery irrespective of geographical location with demonstrable improved patient experience, flexibility and quality of life.
At South Tees Foundation Trust they have developed a protocol that provides a practice framework to ensure safe delivery of chemotherapy, whilst ensuring a high quality service that enables patients to have effective treatment and choice of treatment delivery irrespective of geographical location. Identify inclusion and exclusion criteria, a training package for patients or relatives with an assessment, including risk assessment and manual dexterity.
The Haematology Chemotherapy team developed a protocol providing a practice framework to ensure safe self/carer delivery of chemotherapy, whilst ensuring a quality service that enabled patients to have effective treatment and choice of treatment delivery irrespective of geographical location.
· Feedback demonstrated an improvement in patient experience and quality of life.
· The project also demonstrated better management of capacity and demand.
· The project allowed the team to meet the following criteria in the NHS Outcomes Framework (2012):
* Domain 2 – enhancing quality of life for people with long term conditions were cure is not a viable outcome ensuring best possible, quality of life through, where appropriate, delivery of palliative chemotherapy;
* Domain 3 – helping people recover from episodes of ill health;
* Domain 4 – ensuring that people have a positive experience of care;
* Domain 5 – treating and caring for people in a safe environment.
In June 2016 the project won 3rd place in the Service Improvement category of the Bright Ideas in Health Awards.
For further information on the project, please contact Wendy Anderson, Macmillan Nurse Consultant, Chemotherapy at South Tees Hospitals NHS Trust at [email protected].